Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2012
10/23/2012CA2418802C Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
10/23/2012CA2418411C Inhibitory, monoclonal antibody against blood clotting factor vii-activating protease
10/23/2012CA2412494C Agonist anti-trk-c monoclonal antibodies
10/23/2012CA2386141C A novel polypeptide and gene encoding the same
10/23/2012CA2361009C Her-2/neu fusion proteins
10/23/2012CA2359840C Glycosylated leptin compositions and related methods
10/23/2012CA2257839C Gamma-heregulin
10/18/2012WO2012141791A1 Polyclonal antibody compositions
10/18/2012WO2012141756A2 Voice control of automated heart-lung machine
10/18/2012WO2012141026A1 Fusion protein
10/18/2012WO2012140588A1 Production of heterologous extracellular polypeptides in yarrowia lipolytica
10/18/2012WO2012140171A1 Fermentation process
10/18/2012WO2012139225A1 Fusion proteins and combination vaccines comprising haemophilus influenzae protein e and pilin a
10/18/2012WO2012139179A1 Peptides with antimicrobial activity, drug compositions for the prophylaxis and treatment of animals, compositions for the prophylaxis and treatment of plants, uses of said peptides, and uses of paenibacillus elgii ourofinensis extract
10/18/2012WO2012092374A3 Express humanization of antibodies
10/18/2012US20120266329 Nucleic Acids and Proteins and Methods for Making and Using Them
10/18/2012US20120266264 Monoclonal antibodies against gonadotropin-releasing hormone receptor
10/18/2012US20120264918 Purification method which prevents denaturation of an antibody
10/18/2012US20120264916 Methods of Preventing and Removing Trisulfide Bonds
10/18/2012US20120264914 Spider silk proteins and methods for producing spider silk proteins
10/18/2012US20120264873 Sugar mixtures and methods for production and use thereof
10/18/2012US20120264172 Protein from Photobacterium Damselae and Use Thereof
10/18/2012US20120264171 Stabilization of Alpha-Amylases Towards Calcium Depletion and Acidic PH
10/18/2012US20120264170 Cell line 3m
10/18/2012US20120264169 Dnase expression in recombinant host cells
10/18/2012US20120264168 Zcytor17 heterodimeric cytokine receptor polynucleotides
10/18/2012US20120264158 Anionic acid-labile surfactants and methods of use
10/18/2012US20120264157 Anionic acid-labile surfactants and methods of use
10/18/2012US20120264144 Method for binding a recombinant polypeptide to a carrier
10/18/2012US20120264143 Cytokine-like proteins
10/18/2012US20120263750 Recombinant modified vaccinia ankara (mva) vaccinia virus containing restructured insertion sites
10/18/2012US20120263747 Albumin-Fused Anti-Angiogenesis Peptides
10/18/2012US20120263741 Variants of the major allergen phl p 1 from timothy grass
10/18/2012US20120263728 Method to generate antibodies to ion channels
10/18/2012US20120263727 Method to generate antibodies to ion channels
10/18/2012US20120263724 Escherichia coli o157:h7 proteins and uses thereof
10/18/2012US20120263722 Dual Variable Domain Immunoglobulins and Uses Thereof
10/18/2012US20120263645 Radiolabeled compound directable in vivo to target tissue and use thereof
10/18/2012CA2831964A1 Fermentation process
10/18/2012CA2830786A1 Fusion proteins and combination vaccines comprising haemophilus influenzae protein e and pilin a
10/17/2012EP2511378A1 Method and device for synthesizing protein from dna molecule captured in microchamber
10/17/2012EP2511299A1 Humanized anti-CD70 binding agents and uses thereof
10/17/2012EP2510106A1 Method of reversing immune suppression of langerhans cells
10/17/2012EP2510097A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof
10/17/2012CN1771338B High affinity anti-human IgE antibodies
10/17/2012CN102741423A Dual variable domain immunoglobulins and uses thereof
10/17/2012CN102741422A Coagulation factor ix compositions and methods of making and using same
10/17/2012CN102741421A Method for improving the yield of a polypeptide
10/17/2012CN102741405A System for increasing gene expression, and vector supporting said system
10/17/2012CN102741266A Artificial base pair capable of forming specific base pair
10/17/2012CN102741260A New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody
10/17/2012CN102740877A Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof
10/17/2012CN102732592A Method for preparing freshwater fish bone gelatin by enzyme process
10/17/2012CN102732591A Preparation method of soybean whey polypeptides with liver protection and antioxidation effects
10/17/2012CN102732590A Co-producing process for casomorphin, antibacterial peptide, glycomacropeptide and casein phospho peptide
10/17/2012CN102732589A Method for treating threonine mother liquor
10/17/2012CN102732588A Compositions of aminoacyl-trna synthetase and uses thereof
10/17/2012CN102732587A Purification method for production of swine alpha-interferon
10/17/2012CN102732586A Method for culturing mesenchymal stem cell secretin
10/17/2012CN102732550A Expression of human s1CD80 protein in Pichia pastoris system
10/17/2012CN102732468A Enterococcus faecalis and broad-spectrum bacterium inhibition function thereof
10/17/2012CN102732436A Truncated echinococcus granulosus EG95 protein recombinant Pichia pastoris high-density fermentation process
10/17/2012CN102731651A Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof
10/17/2012CN102731641A Modification of echinococcus granulosus EG95 protein, and expression thereof in yeast
10/17/2012CN102140763B After finishing method for permanently improving hygiene performance of superfine fiber synthetic leather base cloth
10/17/2012CN102080098B Eukaryon expression vector and application thereof to preparing medicament for inhibiting leukemia cell proliferation
10/17/2012CN102051398B Method for preparing half-fin anchovy antibacterial peptides
10/17/2012CN102021216B Extraction method of antialcoholism peptide
10/17/2012CN101967189B RBP4 (Retinol Binding Protein 4) monoclonal antibody and hybridoma cells thereof as well as preparation method and applications thereof
10/17/2012CN101550436B Method for enhancing output of antibacterial substance A21978C
10/16/2012US8288613 Lignan hydroxylase
10/16/2012US8288518 Rearranged squamous cell carcinoma antigen genes
10/16/2012US8288337 Compositions and methods relating to elutable carbohydrate-binding proteins
10/16/2012US8288160 Activation induced deaminase (AID)
10/16/2012US8288140 Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same
10/16/2012US8288130 Polypeptide cleavage process
10/16/2012US8288127 Protein expression systems
10/16/2012US8288126 Methods for making proteins containing free cysteine residues
10/16/2012US8288125 Intergenic regions as insertion sites in the genome of modified vaccinia virus Ankara (MVA)
10/16/2012US8288124 Cloning, expression and purification of recombinant porcine intrinsic factor for use in diagnostic assay
10/16/2012US8288123 Methods and means relating to protein variants
10/16/2012US8288113 Method and device for protein delivery into cells
10/16/2012US8288098 Bioreactive agents
10/16/2012US8287875 Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor
10/16/2012US8287870 Human cytomegalovirus neutralizing antibodies and use thereof
10/16/2012US8287869 Method of treating inflammatory disease by inhibition of IL-17 production
10/16/2012US8287868 bone morphogenic proteins; transforming growth factors; fusion proteins; drug screening; cardiovascular disorders
10/16/2012US8287866 Methods of treating IL-TIF associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors
10/16/2012CA2634992C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
10/16/2012CA2545714C Neutralizing human antibodies to anthrax toxin generated by recall technology
10/16/2012CA2404340C Methods of blocking tissue destruction by autoreactive t cells
10/16/2012CA2132873C Peptides useful for inducing tolerance
10/11/2012WO2012139112A1 Ubiquitin fusions for improving the efficacy of cytosolic acting targeted toxins
10/11/2012WO2012139069A2 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
10/11/2012WO2012138537A1 Compositions and methods for treatment of ovarian, peritoneal, and fallopian tube cancer
10/11/2012WO2012137683A1 Recombinant polypeptide production method
10/11/2012WO2012137676A1 Novel anti-human il-23 receptor antibody
10/11/2012WO2012135955A1 Aqueous process for preparing protein isolate and hydrolyzed protein from an oilseed
10/11/2012WO2012088302A3 Half immunoglobulin binding proteins and uses thereof
10/11/2012US20120260372 TRANSGENIC PLANTS EXPRESSING MODIFIED Cry3A
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 1125